A Seattle stem-cell therapy company was sued by the state attorney general’s office Monday for allegedly falsely marketing its procedures as treatments for COVID-19 and other medical conditions.
Attorney General Bob Ferguson named US Stemology, which runs the Seattle Stem Cell Center in Lower Queen Anne, and company owner Dr. Tami Meraglia in the lawsuit, filed in King County Superior Court.
According to the complaint, US Stemology and Meraglia charged 107 patients for giving them “unproven” stem-cell treatments for COVID, diabetes, lupus, Parkinson’s disease, multiple sclerosis and other serious medical conditions. Some people were charged up to $10,000 out of pocket for participating in the clinic’s “patient funded research,” the complaint says.
“Dr. Meraglia and US Stemology advertised stem cells as a life-changing miracle cure that could treat almost anything — even COVID,” Ferguson said in a statement Monday. “They preyed on people’s fears and frustrations about their health to sell hundreds of thousands of dollars in unproven treatments. Their conduct brings to mind a 21st century version of snake-oil sales tactics.”
The treatment patients were given “essentially the same stem cell procedures as a cure-all for all of these conditions,” the complaint says.
While stem-cell therapy can be used to treat some diseases and medical conditions, including some blood disorders, there is no reliable clinical evidence that cell therapies treat or prevent COVID, or many of these...
Read Full Story:
https://www.seattletimes.com/seattle-news/health/seattle-stem-cell-therapy-co...